Related references
Note: Only part of the references are listed.The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance
David Wroblewski et al.
CARCINOGENESIS (2013)
CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
Patrick A. Ott et al.
CLINICAL CANCER RESEARCH (2013)
FTY720 induces apoptosis in B16F10-NEX2 murine melanoma cells, limits metastatic development in vivo, and modulates the immune system
Felipe V. Pereira et al.
CLINICS (2013)
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
Sahar A. Saddoughi et al.
EMBO MOLECULAR MEDICINE (2013)
Protein phosphatase 2A: a target for anticancer therapy
Danilo Perrotti et al.
LANCET ONCOLOGY (2013)
Nivolumab plus Ipilimumab in Advanced Melanoma
Jedd D. Wolchok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cotargeting histone deacetylases and oncogenic BRAF synergistically kills human melanoma cells by necrosis independently of RIPK1 and RIPK3
F. Lai et al.
CELL DEATH & DISEASE (2013)
PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma
Yan Ye et al.
NATURE COMMUNICATIONS (2013)
FTY720-induced blockage of autophagy enhances anticancer efficacy of milatuzumab in mantle cell lymphoma Is FTY720 the next autophagy-blocking agent in lymphoma treatment?
Lapo Alinari et al.
AUTOPHAGY (2012)
An update in the structure, function, and regulation of V-ATPases: the role of the C subunit
M. Perez-Sayans et al.
BRAZILIAN JOURNAL OF BIOLOGY (2012)
Reactive oxygen species regulation of autophagy in cancer: Implications for cancer treatment
Lin Li et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Induction of brain tumor stem cell apoptosis by FTY720: a potential therapeutic agent for glioblastoma
Adriana Estrada-Bernal et al.
NEURO-ONCOLOGY (2012)
Targeting sphingosine kinase-1 to inhibit melanoma
SubbaRao V. Madhunapantula et al.
PIGMENT CELL & MELANOMA RESEARCH (2012)
Bioenergetics Failure and Oxidative Stress in Brain Stem Mediates Cardiovascular Collapse Associated with Fatal Methamphetamine Intoxication
Faith C. H. Li et al.
PLOS ONE (2012)
Suppression of PP2A is critical for protection of melanoma cells upon endoplasmic reticulum stress
K. H. Tay et al.
CELL DEATH & DISEASE (2012)
FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells
Craig T. Wallington-Beddoe et al.
AUTOPHAGY (2011)
Sphingosine Kinase Inhibitors and Cancer: Seeking the Golden Sword of Hercules
Susan Pyne et al.
CANCER RESEARCH (2011)
NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling
Sharon Biton et al.
CELL (2011)
被撤回的出版物: Antitumor Effects of OSU-2S, a Nonimmunosuppressive Analogue of FTY720, in Hepatocellular Carcinoma (Retracted article. See vol. 76, pg. 1554, 2022)
Hany A. Omar et al.
HEPATOLOGY (2011)
FTY720 induces necrotic cell death and autophagy in ovarian cancer cells A protective role of autophagy
Ning Zhang et al.
AUTOPHAGY (2010)
Essential Requirement for PP2A Inhibition by the Oncogenic Receptor c-KIT Suggests PP2A Reactivation as a Strategy to Treat c-KIT+ Cancers
Kathryn G. Roberts et al.
CANCER RESEARCH (2010)
FTY720 (Fingolimod) Sensitizes Prostate Cancer Cells to Radiotherapy by Inhibition of Sphingosine Kinase-1
Dmitri Pchejetski et al.
CANCER RESEARCH (2010)
The PI3K Pathway As Drug Target in Human Cancer
Kevin D. Courtney et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Understanding Melanoma Signaling Networks as the Basis for Molecular Targeted Therapy
Keiran S. M. Smalley
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Contrasting Effects of Nutlin-3 on TRAIL- and Docetaxel-Induced Apoptosis Due to Upregulation of TRAIL-R2 and Mcl-1 in Human Melanoma Cells
Hsin-Yi Tseng et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Molecular circuits of solid tumors: prognostic and predictive tools for bedside use
Charles Ferte et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C δ signaling
Jui-Hsiang Hung et al.
CANCER RESEARCH (2008)
TNF alpha and reactive oxygen species in necrotic cell death
Michael J. Morgan et al.
CELL RESEARCH (2008)
Downregulating sphingosine kinase-1 for cancer therapy
Olivier Cuvillier
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Targeting sphingosine-I-phosphate for cancer therapy
R. A. Sabbadini
BRITISH JOURNAL OF CANCER (2006)
Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons
JJ Shacka et al.
MOLECULAR PHARMACOLOGY (2006)
Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin
XD Zhang et al.
CLINICAL CANCER RESEARCH (2006)
Antagonism of sphingosine-1-phosphate receptors by FTY720 inhibits angiogenesis and tumor vascularization
K LaMontagne et al.
CANCER RESEARCH (2006)
FTY720 (fingolimod) in renal transplantation
Klemens Budde et al.
CLINICAL TRANSPLANTATION (2006)
FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors
K Chiba
PHARMACOLOGY & THERAPEUTICS (2005)
The S1P-analog FTY720 differentially modulates T-cell homing via HEV:: T-cell-expressed S1P1 amplifies integrin activation in peripheral lymph nodes but not in Peyer patches
C Halin et al.
BLOOD (2005)
Antitumor activity of 3-ingenyl angelate: Plasma membrane and mitochondrial disruption and necrotic cell death
SM Ogbourne et al.
CANCER RESEARCH (2004)
The immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2
SW Paugh et al.
FEBS LETTERS (2003)
Sphingosine-1-phosphate: An enigmatic signalling lipid
S Spiegel et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
The immune modulator FTY720 targets sphingosine 1-phosphate receptors
V Brinkmann et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)